5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immuno-transcriptomic profiling identifies actionable genomic alterations in pediatric solid malignancies
    Meeting Abstract

    Wei, J. S.; Brohl, A. S.; Sindiri, S.; Milewski, D.; Song, Y. K.; Nagaraj, S.; Gangalapudi, V.; Wen, X.; Ladanyi, M.; Khan, J.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
    Meeting Abstract

    Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Shah, H.; Antoine, A.; Ladewig, E.; Gorelick, A.; Lin, T. Y.; Toska, E.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Chromatin accessibility landscape and transcriptome of castration resistant prostate cancers reveals novel subtypes and diverse master regulators
    Meeting Abstract

    Tang, F.; Wong, C. K.; Cohen, S.; Lee, C.; Liu, M.; Bareja, R.; Eng, K.; Beg, S.; Puca, L.; Sternberg, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • OncoKB, a precision oncology knowledgebase
    Meeting Abstract

    Suehnholz, S.; Zhang, H.; Nissan, M.; Kundra, R.; Su, J.; LaFave, L.; Gala, K.; Vanderbilt, C.; Arcila, M.; Ladanyi, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Germline mutation prevalence in young adults with cancer
    Meeting Abstract

    Stadler, Z. K.; Maio, A.; Padunan, A.; Kemel, Y.; Salo-Mullen, E.; Sheehan, M.; Belanfanti, K.; Tejada, P. R.; Birsoy, O.; Mandelker, D.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Resistance to anti-HER2 therapy in HER2+ breast cancer is mediated by genomic alterations that switch pathway dependence from PI3K/AKT to RAS/MAPK
    Meeting Abstract

    Smith, A. E.; Chandarlapaty, S.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Polyethnic-1000: Advancing cancer genomics by studying ethnically diverse, underserved patient populations in New York
    Meeting Abstract

    Robine, N.; Froeling, F.; Hubert, B.; Chu, T.; Chandler, A.; Zody, M. C.; Oschwald, D. M.; Varmus, H. E.; Sawyers, C.; Tuveson, D.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma in a case-control study
    Meeting Abstract

    Purdue, M. P.; Rhee, J.; Moore, L.; Gao, X.; Sun, X.; Kirk, E.; Callahan, C.; Bencko, V.; Janout, V.; Mates, D.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Genetic algorithms to identify homologous recombination deficiency (HRD) in pancreas adenocarcinoma
    Meeting Abstract

    Park, W.; Chen, J.; Chou, J. F.; Iacobuzio-Donague, C.; Riaz, N.; O'Reilly, E. M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The utility of plasma ctDNA for detection of KRAS G12C and other mutations in lung cancers
    Meeting Abstract

    Murciano-Goroff, Y. R.; Arbour, K. C.; Offin, M. D.; Tu, H. Y. Y.; Lebow, E. S.; Shaffer, T. S.; Bertucci, C.; Hosseini, S. A.; Garg, K.; Lim, L. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save